These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38040224)

  • 1. Molecular characterization of STEAP3 in lung squamous cell carcinoma: Regulating EGFR to affect cell proliferation and ferroptosis.
    Shi H; Lei S; Xiong L; Du S; Shi Y
    Arch Biochem Biophys; 2024 Jan; 751():109842. PubMed ID: 38040224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of Lung Squamous Cancer Target HMGCS1 Promotes Cellular Ferroptosis].
    Ni Y; Yang Y; Zhang L
    Zhongguo Fei Ai Za Zhi; 2024 May; 27(5):330-336. PubMed ID: 38880920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Wang W; Cui G; Zhao S
    Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1.
    Yu J; Peng W; Xue Y; Li Y; Yang L; Geng Y
    Allergol Immunopathol (Madr); 2022; 50(5):68-74. PubMed ID: 36086966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma.
    Shan G; Minchao K; Jizhao W; Rui Z; Guangjian Z; Jin Z; Meihe L
    J Pharm Biomed Anal; 2023 May; 229():115346. PubMed ID: 37001272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
    Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
    PeerJ; 2023; 11():e16447. PubMed ID: 38084139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m
    Li Y; Li X; Deng M; Ye C; Peng Y; Lu Y
    Oxid Med Cell Longev; 2022; 2022():4320809. PubMed ID: 36246404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
    Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
    Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway.
    Na J; Zhou W; Yin M; Hu Y; Ma X
    Tissue Cell; 2022 Jun; 76():101795. PubMed ID: 35413491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition.
    Tao Y; Fei L; Chang L; Yongyu L; Jianhui J; Yanan L; Yi R
    Genes Genomics; 2022 Feb; 44(2):211-218. PubMed ID: 34086268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR.
    Wang K; Xu K; Leng X; Han Y; Fang Q
    Technol Cancer Res Treat; 2020; 19():1533033820945807. PubMed ID: 32772818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage.
    Du N; Zhang B; Zhang Y
    Can Respir J; 2023; 2023():4533504. PubMed ID: 37547297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
    Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
    Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis.
    Yan WY; Cai J; Wang JN; Gong YS; Ding XB
    Neoplasma; 2022 May; 69(3):648-656. PubMed ID: 35330996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration.
    Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior 
of Lung Squamous Cell Carcinoma H520 Cells].
    Gou L; He Y; Qiu P; Huang B
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
    Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
    BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2-like tumor-associated macrophages promote epithelial-mesenchymal transition through the transforming growth factor β/Smad/zinc finger e-box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma.
    Sumitomo R; Menju T; Shimazu Y; Toyazaki T; Chiba N; Miyamoto H; Hirayama Y; Nishikawa S; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Ohsumi A; Hamaji M; Sato A; Yoshizawa A; Huang CL; Haga H; Date H
    Cancer Sci; 2023 Dec; 114(12):4521-4534. PubMed ID: 37806311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.